In this issue:
DKA risk with SGLT-2 inhibitors
Semaglutide and kidney function/safety in type 2 diabetes
Undiagnosed type 2 diabetes during pregnancy increases perinatal mortality
Metformin for type 2 diabetes during pregnancy
Adjunctive dapagliflozin with insulin in type 1 diabetes
Fasting glucose level at admission predicts COVID-19 mortality
Hyperglycaemia at admission in patients with COVID-19
Weekly albiglutide in type 2 diabetes inadequately controlled on insulin
Severe hypoglycaemia and causespecific mortality in type 2 diabetes
Intensive glycaemic/BP control and QT prolongation in diabetes
Please login below to download this issue (PDF)